These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15182342)

  • 1. Efficacy and safety of anti-D given by subcutaneous injection to patients with autoimmune thrombocytopenia.
    Meyer O; Kiesewetter H; Hermsen M; Salama A
    Eur J Haematol; 2004 Jul; 73(1):71-2. PubMed ID: 15182342
    [No Abstract]   [Full Text] [Related]  

  • 2. Intramuscular anti-D globulin injection for treatment of chronic idiopathic thrombocytopenic purpura.
    Dutta TK; Hamide A; Goel A; Kashyap R; Ramesh J
    J Assoc Physicians India; 2000 Mar; 48(3):365. PubMed ID: 11229136
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children.
    Freiberg A; Mauger D
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):23-7. PubMed ID: 9523746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children.
    Tarantino MD; Young G; Bertolone SJ; Kalinyak KA; Shafer FE; Kulkarni R; Weber LC; Davis ML; Lynn H; Nugent DJ;
    J Pediatr; 2006 Apr; 148(4):489-94. PubMed ID: 16647411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of anti-D for treatment of adults with immune thrombocytopenia.
    Naithani R; Kumar R; Mahapatra M; Tyagi S; Saxena R
    Platelets; 2009 Nov; 20(7):525-7. PubMed ID: 19852693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid irreversible encephalopathy associated with anti-D immune globulin treatment for idiopathic thrombocytopenic purpura.
    Christopher K; Horkan C; Barb IT; Arbelaez C; Hodgdon TA; Yodice PC
    Am J Hematol; 2004 Nov; 77(3):299-302. PubMed ID: 15495245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin anti-D for treatment of chronic ITP in children.
    Iacobini M; Duse M; Antonetti L; Smacchia MP; Schiavetti A
    Pediatr Blood Cancer; 2010 Dec; 55(7):1435. PubMed ID: 20981698
    [No Abstract]   [Full Text] [Related]  

  • 8. What is the mechanism for acute hemolysis occurring in some patients after intravenous anti-D therapy for immune thrombocytopenic purpura?
    Garratty G
    Transfusion; 2009 Jun; 49(6):1026-31. PubMed ID: 19638151
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura.
    Ramadan KM; El-Agnaf M
    Clin Lab Haematol; 2005 Aug; 27(4):267-9. PubMed ID: 16048495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac) in chronic immune thrombocytopenic purpura.
    Aledort LM; Salama A; Kovaleva L; Robak T; Newland AC; Nugent DJ; Brenner B; Zenker O;
    Hematology; 2007 Aug; 12(4):289-95. PubMed ID: 17654054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed hemolysis after intravenous anti-D immune globulin infusion in a patient with idiopathic thrombocytopenic purpura.
    Rubinstein PG; Chen YH
    Am J Hematol; 2008 Aug; 83(8):684-5. PubMed ID: 18508323
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapid encephalopathy associated with anti-D immune globulin treatment for idiopathic thrombocytopenic purpura.
    Golla S; Horkan C; Dogaru G; Teske TE; Christopher K
    Acta Haematol; 2008; 120(2):100-3. PubMed ID: 18957844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-D treatment in thrombocytopenia refractory to conventional therapies.
    Adorno G; Lo Pinto FR; Cox MC; Bruno A; Masi M; Stipa E; Montanaro M; Papa G
    Haematologica; 1992; 77(1):97-8. PubMed ID: 1327999
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute liver failure occurring immediately following anti-D immune globulin infusion in a patient with chronic hepatitis B infection.
    Abdelmalek MF; Hellner LB; Zumberg M; Melgen VW; Lottenberg R
    Dig Dis Sci; 2007 Apr; 52(4):914-9. PubMed ID: 17347887
    [No Abstract]   [Full Text] [Related]  

  • 15. After eight-year-tolerance minimal i.v. anti-D infusions unleash hemolysis in a patient with immune thrombocytopenic purpura (ITP).
    Rewald MD; Francischetti MM
    Transfus Apher Sci; 2004 Apr; 30(2):105-10. PubMed ID: 15062747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic thrombocytopenic purpura following allogeneic bone marrow transplantation--treatment with anti-D immunoglobulin.
    Lee SJ; Churchill WH; Konugres A; Gilliland DG; Antin JH
    Bone Marrow Transplant; 1997 Jan; 19(2):173-4. PubMed ID: 9116615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How we use WinRho in patients with idiopathic thrombocytopenic purpura.
    Stotler BA; Schwartz J
    Transfusion; 2015 Nov; 55(11):2547-50. PubMed ID: 26094894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous anti-D treatment of idiopathic thrombocytopenic purpura in children.
    Kjaersgaard M; Edslev PW; Hasle H
    Pediatr Blood Cancer; 2009 Dec; 53(7):1315-7. PubMed ID: 19722275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura.
    Kumar M; Vik TA; Johnson CS; Southwood ME; Croop JM
    Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fc receptor blockade in patients with chronic refractory autoimmune thrombocytopenia].
    Ruiz-Argüelles GJ; Ruiz-Argüelles A; Marín-López A
    Rev Invest Clin; 1993; 45(2):182-3. PubMed ID: 8393212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.